Altre lingue Q BioMed Inc.

Azioni

QBIO

US74736N1054

Tempo differito OTC Markets Altri mercati azionari 15:46:06 10/05/2024			Variaz. 5gg	Var. 1 gen.
0,000001 ^USD	-99,83%		0,00%	-50,00%

2023	Q BioMed Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 28 febbraio 2023	CI
2023	Q BioMed Inc. riporta i risultati degli utili per l'intero anno conclusosi il 30 novembre 2022	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Q BioMed Inc. Provides Update to Shareholders	23/06/23
Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	16/06/23
Q BioMed Inc. Reports Earnings Results for the Full Year Ended November 30, 2022	26/05/23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe	17/04/23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe	14/04/23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office	13/02/23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office	10/02/23
Q BioMed Inc.'s Chemotherapeutic Uttroside B Receives Notice of Allowance for Patent from United States Patent Office	10/02/23
Q BIOMED INC. : Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	18/11/22
Q BIOMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)	03/11/22
Q BioMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	03/11/22
Q BIOMED PROVIDES SHAREHOLDER UPDATE	11/10/22
Q BIOMED ANNOUNCES ISSUANCE OF PATENT FOR GROUNDBREAKING GDF15 BIOMARKER	27/09/22
Q BioMed Inc. Announces Issuance of Patent for Groundbreaking Gdf15 Biomarker	27/09/22
Q BioMed Inc. Provides Update to Shareholders	29/07/22
Q BioMed Inc. Reports Second Quarter Revenues in 2022	29/07/22
Q BioMed : Quarterly Report for Quarter Ending May 31, 2022 (Form 10-Q)	28/07/22
Q BIOMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)	28/07/22
Q BioMed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	28/07/22
Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer	26/07/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Q BioMed Inc.

Azioni

QBIO

US74736N1054

Altre lingue

Filtri